Results 111 to 120 of about 24,553 (208)

Microbiome Therapeutics for Clostridioides difficile Infection. [PDF]

open access: yesInfect Dis Clin North Am
Lucky CW   +4 more
europepmc   +1 more source

Structural determinants of SlpA-mediated phage recognition in Clostridioides difficile. [PDF]

open access: yesPLoS Pathog
Royer ALM   +5 more
europepmc   +1 more source

Factors associated with failure of fecal microbiota transplant for recurrent Clostridioides difficile infection

open access: gold
Joseph Nguyen   +7 more
openalex   +1 more source

In silico interaction of catalytic domain of Clostridioides difficile toxins TcdA and TcdB with some selected compounds from the SuperNatural 3.0 database

open access: yesKuwait Journal of Science
Clostridioides difficile is a pathogenic bacterium responsible for antibiotic-associated diarrhea globally. The pathogenesis of this bacterium is due to its virulence toxins, which inactivate the small GTPases from the Rho and Ras families in host cells,
doaj   +1 more source

Screening and targeted prophylaxis for Clostridioides difficile infection. [PDF]

open access: yesClin Microbiol Infect
Ziegler MJ   +10 more
europepmc   +1 more source

Raja 42, a novel gamma lactam compound, is effective against Clostridioides difficile

open access: gold, 2021
Alexis Fong   +5 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy